Correction to: Clinical and Experimental Nephrology (2019) 23:739–748 https://doi.org/10.1007/s10157-019-01692-y
The article “Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients” written by Kazuhiko Tsuruya · Ryutaro Shimazaki · Masafumi Fukagawa · Tadao Akizawa on behalf of Evocalcet Study Group, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 6th April 2019 without open access.
With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 20th June 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The original article has been corrected.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Tsuruya, K., Shimazaki, R., Fukagawa, M. et al. Correction to: Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients. Clin Exp Nephrol 23, 1173 (2019). https://doi.org/10.1007/s10157-019-01758-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-019-01758-x